يعرض 1 - 10 نتائج من 30 نتيجة بحث عن '"Pelletier, Kathleen"', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment

    المؤلفون: Lin, Swan, Gong, Jason, Canas, George C., Winkle, Peter, Pelletier, Kathleen, LaBadie, Robert R., Ginman, Katherine, Pithavala, Yazdi K.

    المصدر: European Journal of Drug Metabolism and Pharmacokinetics ; volume 47, issue 3, page 441-441 ; ISSN 0378-7966 2107-0180

    مصطلحات موضوعية: Pharmacology (medical), Pharmacology

    الإتاحة: https://doi.org/10.1007/s13318-022-00759-8Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment

    المؤلفون: Lin, Swan, Gong, Jason, Canas, George C., Winkle, Peter, Pelletier, Kathleen, LaBadie, Robert R., Ginman, Katherine, Pithavala, Yazdi K.

    المساهمون: Pfizer

    المصدر: European Journal of Drug Metabolism and Pharmacokinetics ; volume 47, issue 2, page 235-245 ; ISSN 0378-7966 2107-0180

    مصطلحات موضوعية: Pharmacology (medical), Pharmacology

    الإتاحة: https://doi.org/10.1007/s13318-021-00747-4Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    A Phase 1 study of anti-interferon-β antibody in healthy Japanese participants

    المؤلفون: Arnab Mukherjee, Banfield Christopher, Christopher Banfield, Chu Myron, Elena Peeva, Hiroki Yoshimatsu, Junichi Tabira, Kathleen Pelletier, Kenji Takazawa, Michael Vincent, Mukherjee Arnab, Myron Chu, Peeva Elena, Pelletier Kathleen, Vincent Michael, Yamato Sano, Yuichi Yamamoto, 佐野 大和, 吉松 宏樹, 山本 有一, 田平 淳一, 高沢 謙二

    المصدر: Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics. 2022, :1-027

    View record in JSTAGE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed‐Dose Combination Tablets to Canadian‐Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States

    المؤلفون: Dawra, Vikas Kumar, Pelletier, Kathleen, Matschke, Kyle, Shi, Haihong, Hickman, Anne, Zhou, Susan, Krishna, Rajesh, Sahasrabudhe, Vaishali

    المصدر: Clinical Pharmacology in Drug Development ; volume 10, issue 5, page 510-520 ; ISSN 2160-763X 2160-7648

    الإتاحة: https://doi.org/10.1002/cpdd.884Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Bioequivalence of Ertugliflozin/Sitagliptin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components

    المؤلفون: Fediuk, Daryl J., Matschke, Kyle, Liang, Yali, Pelletier, Kathleen B., Wei, Hua, Shi, Haihong, Bass, Almasa, Hickman, Anne, Terra, Steven G., Zhou, Susan, Krishna, Rajesh, Sahasrabudhe, Vaishali

    المساهمون: Pfizer

    المصدر: Clinical Pharmacology in Drug Development ; volume 8, issue 7, page 884-894 ; ISSN 2160-763X 2160-7648

    الإتاحة: https://doi.org/10.1002/cpdd.722Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Bioequivalence of Ertugliflozin/Metformin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components

    المؤلفون: Dawra, Vikas Kumar, Liang, Yali, Wei, Hua, Pelletier, Kathleen, Shi, Haihong, Hickman, Anne, Bass, Almasa, Terra, Steven G., Zhou, Susan, Krishna, Rajesh, Sahasrabudhe, Vaishali

    المساهمون: Merck Sharp and Dohme, Pfizer

    المصدر: Clinical Pharmacology in Drug Development ; volume 9, issue 1, page 50-61 ; ISSN 2160-763X 2160-7648

    الإتاحة: https://doi.org/10.1002/cpdd.703Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Safety, Tolerability, and Pharmacokinetics of PF‐06823859, an Anti–Interferon β Monoclonal Antibody: A Randomized, Phase I, Single‐ and Multiple‐Ascending‐Dose Study

    المؤلفون: Neelakantan, Srividya, Oemar, Barry, Johnson, Kristen, Rath, Natalie, Salganik, Mikhail, Berman, Gabe, Pelletier, Kathleen, Cox, Lori, Page, Karen, Messing, Dean, Tarabar, Sanela

    المصدر: Clinical Pharmacology in Drug Development ; volume 10, issue 3, page 307-316 ; ISSN 2160-763X 2160-7648

    الإتاحة: https://doi.org/10.1002/cpdd.887Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية
    Population Pharmacokinetics of Inotuzumab Ozogamicin (InO) As Single Agent in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia - Results from the ITCC-059 Phase IA and Phase II Trial

    المؤلفون: Pennesi, Edoardo, Brivio, Erica, Pelletier, Kathleen B., Chen, Ying, Huitema, Alwin D.R., Jiang, Yilin, Ammerlaan, Anneke C.J., Sleight, Barbara, Locatelli, Franco, Van Der Sluis, Inge M., Rossig, Claudia, Chen-Santel, Christiane, Bielorai, Bella, Petit, Arnaud, Stary, Jan, Sramkova, Lucie, Díaz de Heredia Rubio, Cristina, Rives, Susana, O'Marcaigh, Aengus, Rizzari, Carmelo, Engstler, Gernot, Nysom, Karsten, Rubio-San-Simón, Alba, Bautista Sirvent, Francisco J., Bruno, Bénédicte, Bertrand, Yives, Brethon, Benoit, Rialland, Fanny, Plat, Genevieve, Dirksen, Uta, Garrett, May, Zwaan, Christian M.

    المصدر: Blood; November 2022, Vol. 140 Issue: Supplement 1 p8845-8847, 3p

    النص الكامل

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed‐Dose Combination Tablets to Canadian‐Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States.

    المؤلفون: Dawra, Vikas Kumar1 (AUTHOR) Vikas.K.Dawra@pfizer.com, Pelletier, Kathleen2 (AUTHOR), Matschke, Kyle3 (AUTHOR), Shi, Haihong2 (AUTHOR), Hickman, Anne2 (AUTHOR), Zhou, Susan4 (AUTHOR), Krishna, Rajesh4,5 (AUTHOR), Sahasrabudhe, Vaishali2 (AUTHOR)

    المصدر: Clinical Pharmacology in Drug Development. May2021, Vol. 10 Issue 5, p510-520. 11p.

    مصطلحات موضوعية: *METFORMIN, *SODIUM-glucose cotransporter 2 inhibitors, *TYPE 2 diabetes

    الشركة/الكيان: EUROPEAN Union


    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Safety, Tolerability, and Pharmacokinetics of PF‐06823859, an Anti–Interferon β Monoclonal Antibody: A Randomized, Phase I, Single‐ and Multiple‐Ascending‐Dose Study.

    المؤلفون: Neelakantan, Srividya, Oemar, Barry, Johnson, Kristen, Rath, Natalie, Salganik, Mikhail, Berman, Gabe, Pelletier, Kathleen, Cox, Lori, Page, Karen, Messing, Dean, Tarabar, Sanela

    المصدر: Clinical Pharmacology in Drug Development; Mar2021, Vol. 10 Issue 3, p307-316, 10p

    مصطلحات موضوعية: PHARMACOKINETICS, SYSTEMIC lupus erythematosus


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث